TNFSF10 and glioblastoma: Finally, using fibroblasts engineered to constitutively secrete the anticancer protein TNF-related apoptosis inducing ligand (TRAIL) as a model cell therapy, we demonstrated ability for the bioprinted constructs to improve therapeutic outcomes in a model of glioblastoma (GBM) resection in mice compared to controls.